Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Inventory Average (2011 - 2026)

Mimedx recorded quarterly Inventory Average of $25.8 million in Q1 2026, down 0.53% quarter-over-quarter from $25.9 million in Q4 2025, and up 7.71% year-over-year from $23.9 million in Q1 2025.

Mimedx's Inventory Average history runs 15 years deep, the most recent figure standing at $25.8 million for Q1 2026.

  • In Q1 2026, Inventory Average rose 7.71% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $25.8 million (up 7.71% YoY), while the FY2025 annual figure was $24.6 million, up 9.63% from the prior year.
  • Inventory Average came in at $25.8 million for Q1 2026 at Mimedx, down from $25.9 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $25.9 million in Q4 2025 to a low of $12.3 million in Q1 2022.
  • A 5-year average of $20.1 million and a median of $22.7 million in 2024 frame the typical range for Inventory Average.
  • Across the five-year window, Inventory Average jumped 63.34% in 2024 and decreased 1.11% in 2025, its largest moves.
  • Mimedx's Inventory Average stood at $13.6 million in 2022, then soared by 47.61% to $20.0 million in 2023, then increased by 19.87% to $24.0 million in 2024, then climbed by 7.88% to $25.9 million in 2025, then retreated by 0.53% to $25.8 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $25.8 million, $25.9 million, and $25.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.59 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.73 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.15 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 83.37 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 25.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 25.78 Mn
Dec 31, 2025 25.92 Mn
Sep 30, 2025 25.70 Mn
Jun 30, 2025 24.48 Mn
Mar 31, 2025 23.94 Mn
Dec 31, 2024 24.03 Mn
Sep 30, 2024 24.65 Mn
Jun 30, 2024 24.76 Mn
Mar 31, 2024 22.74 Mn
Dec 31, 2023 20.04 Mn
Sep 30, 2023 17.94 Mn
Jun 30, 2023 15.74 Mn
Mar 31, 2023 13.92 Mn
Dec 31, 2022 13.58 Mn
Sep 30, 2022 13.68 Mn
Jun 30, 2022 13.28 Mn
Mar 31, 2022 12.28 Mn
Dec 31, 2021 11.29 Mn
Sep 30, 2021 10.67 Mn
Jun 30, 2021 10.86 Mn
Mar 31, 2021 10.97 Mn
Dec 31, 2020 10.69 Mn
Sep 30, 2020 10.79 Mn
Jun 30, 2020 9.91 Mn
Mar 31, 2020 9.18 Mn
Dec 31, 2019 10.57 Mn
Sep 30, 2019 13.49 Mn
Jun 30, 2019 15.69 Mn
Mar 31, 2019 16.21 Mn
Dec 31, 2017 9.94 Mn
Sep 30, 2017 12.73 Mn
Jun 30, 2017 15.54 Mn
Mar 31, 2017 15.96 Mn
Dec 31, 2016 17.09 Mn
Sep 30, 2016 17.76 Mn
Jun 30, 2016 17.59 Mn
Mar 31, 2016 12.71 Mn
Dec 31, 2015 6.56 Mn
Sep 30, 2015 4.76 Mn
Jun 30, 2015 4.05 Mn
Mar 31, 2015 4.69 Mn
Dec 31, 2014 4.94 Mn
Sep 30, 2014 4.48 Mn
Jun 30, 2014 3.93 Mn
Mar 31, 2014 3.76 Mn
Dec 31, 2013 4.21 Mn
Sep 30, 2013 4.38 Mn
Jun 30, 2013 4.18 Mn
Mar 31, 2013 3.58 Mn
Dec 31, 2012 2.44 Mn
Sep 30, 2012 1.44 Mn
Jun 30, 2012 906,155.00
Mar 31, 2012 754,059.00
Dec 31, 2011 660,870.50
Sep 30, 2011 585,528.00